IDEAYA Biosciences

Quick facts

Phase 2 pipeline

• IDE196 · Oncology
  Selective inhibitor of MEK1/2

Phase 1 pipeline

• IDE-161
• IDE161
• IDE397
• IDE849
• IDE892

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• IDEAYA Biosciences portfolio CI brief
• IDEAYA Biosciences pipeline updates RSS